Volume 35, Issue 11 pp. 1551-1557
Original Article

Primary sarcomas of the salivary glands: Case series and literature review

Cara C. Cockerill MD

Cara C. Cockerill MD

The University of Texas Medical School at Houston, Houston, Texas

Search for more papers by this author
Shiva Daram BA

Shiva Daram BA

Office of Student Affairs, Baylor College of Medicine, Houston, Texas

Search for more papers by this author
Adel K. El–Naggar MD

Adel K. El–Naggar MD

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Search for more papers by this author
Ehab Y. Hanna MD

Ehab Y. Hanna MD

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

Search for more papers by this author
Randal S. Weber MD

Randal S. Weber MD

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

Search for more papers by this author
Michael E. Kupferman MD

Corresponding Author

Michael E. Kupferman MD

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, 1400 Pressler, Unit 1445, Houston, TX 77030. E-mail: [email protected]Search for more papers by this author
First published: 01 June 2013
Citations: 26
Ehab Y. Hanna, MD, was recused from consideration of this manuscript.

Abstract

Background

Mesenchymal malignancies of salivary origin are rare and are histologically diverse. We reviewed our experience with these tumors, as well as the published literature, with an emphasis on treatment modalities and prognosis.

Methods

We identified 17 patients treated for malignant mesenchymal cell tumors at The University of Texas MD Anderson Cancer Center between 1990 and 2007. We compared our results to the literature from January 1990 to July 2010.

Results

Tumors were located primarily in the parotid gland and were primarily T1 tumors (<5 cm). All patients were treated with surgical resection, and 13 patients were given adjuvant therapy. Seven patients (41%) had recurrence, and 4 developed distant metastases. The overall 5-year and 10-year survival rates were 42% and 20%, respectively.

Conclusions

Our case series and literature review show that sarcomas of the salivary glands have a high rate of recurrence and are associated with a poor prognosis. © 2013 Wiley Periodicals, Inc. Head Neck, 35: 1551–1557, 2013

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.